|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 217/02 | |
| C07D 217/24 | |||
| C07D 401/12 | |||
| C07D 409/12 | |||
| C07D 417/12 | |||
| C07C 237/00 | |||
| A61P 27/00 | |||
| A61K 31/33 | |||
| A61K 31/47 |
| (11) | Patento numeris | 3354643 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18160338.2 |
| Europos patento paraiškos padavimo data | 2010-01-27 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-01 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-28 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 174672 P | 2009-05-01 | US |
| (72) |
deLong, Mitchell A., US
Sturdivant, Jill Marie, US
Royalty, Susan M., US
|
| (73) |
Aerie Pharmaceuticals, Inc.,
550 Hills Drive, Third Floor, Bedminster, NJ 07921,
US
|
| (54) | DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE |
| DUAL MECHANISM INHIBITORS FOR THE TREATMENT OF DISEASE |